The following cytokines, IL-1β, IL-6, IL-8, and IL-10, unlike IL-1Ra, IL-13, and IFNγ, demonstrated high diagnostic potential for clinical prognosis for GBM patients, especially in models with neutrophil-to-lymphocyte ratio. Here, IL13 is linked to glioblastoma.